Rosen CJ - Search Results

1

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.

Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Eastell R, et al. Among authors: rosen cj. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. J Clin Endocrinol Metab. 2019. PMID: 30907953

2

Osteoporotic vertebral fractures in postmenopausal women.

Millard PS, Rosen CJ, Johnson KH. Millard PS, et al. Among authors: rosen cj. Am Fam Physician. 1997 Mar;55(4):1315-22. Am Fam Physician. 1997. PMID: 9092292 Review.

3

The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.

Rosen CJ, Chesnut CH 3rd, Mallinak NJ. Rosen CJ, et al. J Clin Endocrinol Metab. 1997 Jun;82(6):1904-10. doi: 10.1210/jcem.82.6.4004. J Clin Endocrinol Metab. 1997. PMID: 9177404 Clinical Trial.

4

The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy.

Rosen CJ, Kessenich CR. Rosen CJ, et al. Endocrinol Metab Clin North Am. 1997 Jun;26(2):295-311. doi: 10.1016/s0889-8529(05)70248-6. Endocrinol Metab Clin North Am. 1997. PMID: 9193885 Review.

5

Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.

Storm D, Eslin R, Porter ES, Musgrave K, Vereault D, Patton C, Kessenich C, Mohan S, Chen T, Holick MF, Rosen CJ. Storm D, et al. Among authors: rosen cj. J Clin Endocrinol Metab. 1998 Nov;83(11):3817-25. doi: 10.1210/jcem.83.11.5289. J Clin Endocrinol Metab. 1998. PMID: 9814452 Clinical Trial.

6

Pathogenesis of osteoporosis.

Rosen CJ. Rosen CJ. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Jun;14(2):181-93. doi: 10.1053/beem.2000.0068. Baillieres Best Pract Res Clin Endocrinol Metab. 2000. PMID: 11035901 Review.

7

Clinical review 123: Anabolic therapy for osteoporosis.

Rosen CJ, Bilezikian JP. Rosen CJ, et al. J Clin Endocrinol Metab. 2001 Mar;86(3):957-64. doi: 10.1210/jcem.86.3.7366. J Clin Endocrinol Metab. 2001. PMID: 11238469 Review.

8

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators. Black DM, et al. Among authors: rosen cj. N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500804 Free article. Clinical Trial.

9

Vignettes in osteoporosis: a road map to successful therapeutics.

Rosen CJ, Black DM, Greenspan SL. Rosen CJ, et al. J Bone Miner Res. 2004 Jan;19(1):3-10. doi: 10.1359/JBMR.0301216. J Bone Miner Res. 2004. PMID: 14753730 Free article.

10

What's new with PTH in osteoporosis: where are we and where are we headed?

Rosen CJ. Rosen CJ. Trends Endocrinol Metab. 2004 Jul;15(5):229-33. doi: 10.1016/j.tem.2004.05.005. Trends Endocrinol Metab. 2004. PMID: 15223053 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters